Chronic Obstructive Pulmonary Disease (COPD) is a lung disease that makes it hard to breathe. This study tests a new medicine called Solrikitug to see if it is safe and works well for people with COPD. People in the study will get either Solrikitug or a placebo (a fake treatment) without knowing which one they are getting. The medicine is given by a shot under the skin, just like a vaccine. The study lasts for 12 weeks, and doctors will keep checking on the patients for another 16 weeks after the treatment ends.

• The study lasts for a total of 28 weeks, including follow-up.
• Participants must visit the study site for their injections and follow-ups.
• There may be some risks, like allergic reactions to the medicine.

To join, you must be 40-75 years old and have had COPD for at least a year. You should also be taking inhalers for your COPD. You cannot join if you have other serious health issues, are pregnant, or have had recent lung surgery. Talk to your doctor to see if this study is right for you.